Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab
| Autor: | Delasos, Lukas, Wei, Wei, Hassan, Khaled A., Pennell, Nathan A., Patil, Pradnya, Stevenson, James |
|---|---|
| Zdroj: | In Clinical Lung Cancer September 2023 24(6):e205-e213 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect